<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lenco J</submitter><funding>NCI NIH HHS</funding><pagination>7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3331852</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>Naturally occurring native peptides provide important information about physiological states of an organism and its changes in disease conditions but protocols and methods for assessing their abundance are not well-developed. In this paper, we describe a simple procedure for the quantification of non-tryptic peptides in body fluids. The workflow includes an enrichment step followed by two-dimensional fractionation of native peptides and MS/MS data management facilitating the design and validation of LC- MRM MS assays. The added value of the workflow is demonstrated in the development of a triplex LC-MRM MS assay used for quantification of peptides potentially associated with the progression of liver disease to hepatocellular carcinoma.</pubmed_abstract><journal>Proteome science</journal><pubmed_title>MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.</pubmed_title><pmcid>PMC3331852</pmcid><funding_grant_id>R01 CA135069</funding_grant_id><pubmed_authors>Lenco J</pubmed_authors><pubmed_authors>Lan R</pubmed_authors><pubmed_authors>Goldman R</pubmed_authors><pubmed_authors>Edwards N</pubmed_authors></additional><is_claimable>false</is_claimable><name>MS/MS library facilitated MRM quantification of native peptides prepared by denaturing ultrafiltration.</name><description>Naturally occurring native peptides provide important information about physiological states of an organism and its changes in disease conditions but protocols and methods for assessing their abundance are not well-developed. In this paper, we describe a simple procedure for the quantification of non-tryptic peptides in body fluids. The workflow includes an enrichment step followed by two-dimensional fractionation of native peptides and MS/MS data management facilitating the design and validation of LC- MRM MS assays. The added value of the workflow is demonstrated in the development of a triplex LC-MRM MS assay used for quantification of peptides potentially associated with the progression of liver disease to hepatocellular carcinoma.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Feb</publication><modification>2025-04-04T09:12:35.771Z</modification><creation>2019-03-27T00:52:31Z</creation></dates><accession>S-EPMC3331852</accession><cross_references><pubmed>22304756</pubmed><doi>10.1186/1477-5956-10-7</doi></cross_references></HashMap>